I apologize for my initial reaction. I was on investor hub

New Post Public Reply Private Reply Replies (1) Message Board
JSMChi petemantx #62252
437
I apologize for my initial reaction. I was on investor hub and MXAMDUD is spreading so many half truths and lies that I was a bit revved up. Oralogik is and will be a MAJOR breakthrough in drug delivery moving forward. IPIX will boom being partnered with this BDD technology. It's a major breakthrough for IBS sufferers that they've discovered how to pinpoint deliver to various areas of the colon. It's actually a positive thing that it does not release into the blood stream upon swallowing. That would lead to more toxicities and unrelated problems, in addition to lessening the positive effects it would have once reaching the targeted area in the colon. A pill for IBS, and a rinse and spit for mucositis should literally make big pharma stand up and take notice! Both markets are in the billions, and both markets are untapped!! (first IBS oral). These are both major markets that entire companies are based upon, and IPIX has two!!! These are NOT rare disease , these drugs if /when FDA and EMA approved will be unbelievable. What we need now is VISIBILITY amongst big investors and Big Pharma!!! Let's hope Locust Walk is doing this as we speak. The science is good, we just need cash to move into phase 3.
1

Innovation Pharmaceuticals Inc (IPIX) Stock Research Links

IPIX Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Chipotle's Market Struggles Amid Activist Investor's Bet

Updated Category News Views 208

Current Landscape Chipotle Mexican Grill (NYSE:CMG) stands at a crossroads, teetering on the edge of a significant market shift. I mean, it's like watching a seesaw in a hurricane. Now, here's the kicker—activist investor Dan Loeb's Third Point LLC jumped in, acquiring a 4.75 million share slice of the fast-casual chain in late 2025, right when CMG’s shares are...

Continue Reading
Hims & Hers Health Joins S&P SmallCap 600 Amid Changes

Updated Category News Views 223

Hims & Hers Health Set to Join the S&P SmallCap 600 Hims & Hers Health, Inc. (NYSE: HIMS) is making waves in the financial markets as it prepares to join the S&P SmallCap 600. This transition marks a significant milestone for the company, reflecting its growth and stability in the healthcare sector. Details of the Market Transition The effective date for the change is set...

Continue Reading
Market Overview: Spain's Stocks Experience Slight Decline

Updated Category News Views 63

Examining Spain's Stock Market Trends Recently, Spain's stock market has shown a slight decline, particularly noticeable at the close on a Friday. The key index, the IBEX 35, which tracks the performance of the country's leading companies, experienced a minor drop of 0.11%. This downturn is largely due to losses in important sectors, including Building & Construction,...

Continue Reading
Discover Your Dream Home in Valencia's Volara Community

Updated Category News Views 335

Toll Brothers Presents Final Opportunity in Valencia Toll Brothers, Inc. (NYSE: TOL), recognized as the nation's premier luxury home builder, has announced the final chance for home buyers to purchase a new home at the prestigious Volara community. Nestled within the dynamic Valencia master-planned community, this offering is particularly exciting as there are only five...

Continue Reading
U.S. Stock Market Soars: Dow Hits New Heights with Gains

Updated Category News Views 175

U.S. stock markets turned up the heat back in that session—gains across key sectors painted a picture of resilience, especially in Oil & Gas, Technology, and Healthcare. You could feel the confidence bubbling up among investors, kinda like when you finally hit a good coffee after a long night shift. Dow Jones Soars: New All-Time High or Just a Mirage? The Dow Jones...

Continue Reading